AlphaCrest Capital Management’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
2022
Q1
$84K Sell
2021
Q4
$1.08M Buy
2021
Q3
$390K Sell
2021
Q2
$2.1M Buy
2021
Q1
$230K Sell
2020
Q4
$208K Sell
2020
Q3
$316K Buy
2019
Q4
Sell
2019
Q3
$268K Buy